Study of BMS-986453 in Newly Diagnosed Multiple Myeloma
NCT07333261
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
BMS-986453
Sponsor
Susan Bal
Collaborators
Bristol-Myers Squibb